These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813 [TBL] [Abstract][Full Text] [Related]
26. Psychedelic medicines for mood disorders: current evidence and clinical considerations. Sarris J; Pinzon Rubiano D; Day K; Galvão-Coelho NL; Perkins D Curr Opin Psychiatry; 2022 Jan; 35(1):22-29. PubMed ID: 34855694 [TBL] [Abstract][Full Text] [Related]
27. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
28. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G J Neurosci; 2021 Feb; 41(5):891-900. PubMed ID: 33257322 [TBL] [Abstract][Full Text] [Related]
29. The promises and perils of psychedelic pharmacology for psychiatry. McClure-Begley TD; Roth BL Nat Rev Drug Discov; 2022 Jun; 21(6):463-473. PubMed ID: 35301459 [TBL] [Abstract][Full Text] [Related]
30. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. Garcia-Romeu A; Richards WA Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079 [TBL] [Abstract][Full Text] [Related]
31. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives. Kaypak AC; Raz A Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848 [TBL] [Abstract][Full Text] [Related]
32. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy. Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812 [TBL] [Abstract][Full Text] [Related]
33. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness. Holoyda B Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796 [TBL] [Abstract][Full Text] [Related]
34. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521 [TBL] [Abstract][Full Text] [Related]
35. Role of Psychedelics in Treatment-Resistant Depression. Kamal S; Jha MK; Radhakrishnan R Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346 [TBL] [Abstract][Full Text] [Related]
36. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Sousa TR; Rema J; Machado S; Novais F Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736 [TBL] [Abstract][Full Text] [Related]
37. Psychedelics in the treatment of unipolar mood disorders: a systematic review. Rucker JJ; Jelen LA; Flynn S; Frowde KD; Young AH J Psychopharmacol; 2016 Dec; 30(12):1220-1229. PubMed ID: 27856684 [TBL] [Abstract][Full Text] [Related]
38. A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Luoma JB; Chwyl C; Bathje GJ; Davis AK; Lancelotta R J Psychoactive Drugs; 2020; 52(4):289-299. PubMed ID: 32529966 [TBL] [Abstract][Full Text] [Related]